These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 16763676)

  • 21. New opportunities for biocatalysis: making pharmaceutical processes greener.
    Woodley JM
    Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous processes for the production of pharmaceutical intermediates and active pharmaceutical ingredients.
    LaPorte TL; Wang C
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):738-45. PubMed ID: 17987525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of parallel chemistry in drug discovery.
    Edwards PJ
    IDrugs; 2006 May; 9(5):347-53. PubMed ID: 16676271
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Chemical drug development].
    Castro B
    Ann Pharm Fr; 2002 May; 60(3):147-9. PubMed ID: 12050592
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular Complexity as a Driver for Chemical Process Innovation in the Pharmaceutical Industry.
    Caille S; Cui S; Faul MM; Mennen SM; Tedrow JS; Walker SD
    J Org Chem; 2019 Apr; 84(8):4583-4603. PubMed ID: 30916557
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Race for molecular summits.
    Service RF
    Science; 1999 Jul; 285(5425):184-5, 187. PubMed ID: 10428711
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug industry looks to the lab instead of rainforest and reef.
    Service RF
    Science; 1999 Jul; 285(5425):186. PubMed ID: 10428712
    [No Abstract]   [Full Text] [Related]  

  • 28. [Strategy of molecular drug design: hits, leads and drug candidates].
    Guo ZR
    Yao Xue Xue Bao; 2008 Sep; 43(9):898-904. PubMed ID: 19048779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. When poor solubility becomes an issue: from early stage to proof of concept.
    Stegemann S; Leveiller F; Franchi D; de Jong H; Lindén H
    Eur J Pharm Sci; 2007 Aug; 31(5):249-61. PubMed ID: 17616376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biocatalysis in development of green pharmaceutical processes.
    Tao J; Xu JH
    Curr Opin Chem Biol; 2009 Feb; 13(1):43-50. PubMed ID: 19264533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosage form design and development.
    Allen LV
    Clin Ther; 2008 Nov; 30(11):2102-11. PubMed ID: 19108798
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Forging synergies in drug discovery.
    Nat Chem Biol; 2008 Feb; 4(2):83. PubMed ID: 18202672
    [No Abstract]   [Full Text] [Related]  

  • 33. Greener and sustainable approaches to the synthesis of pharmaceutically active heterocycles.
    Polshettiwar V; Varma RS
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):723-37. PubMed ID: 17987524
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enabling continuous-flow chemistry in microstructured devices for pharmaceutical and fine-chemical production.
    Kockmann N; Gottsponer M; Zimmermann B; Roberge DM
    Chemistry; 2008; 14(25):7470-7. PubMed ID: 18613163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Strength and honor through the pharmaceutical industry's embrace of green chemistry?
    Fortunak J; Confalone PN; Grosso JA
    Curr Opin Drug Discov Devel; 2007 Nov; 10(6):651-3. PubMed ID: 17987518
    [No Abstract]   [Full Text] [Related]  

  • 36. Emerging Trends in Flow Chemistry and Applications to the Pharmaceutical Industry.
    Bogdan AR; Dombrowski AW
    J Med Chem; 2019 Jul; 62(14):6422-6468. PubMed ID: 30794752
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modern natural products chemistry and drug discovery.
    Ojima I
    J Med Chem; 2008 May; 51(9):2587-8. PubMed ID: 18393400
    [No Abstract]   [Full Text] [Related]  

  • 38. Chemical process research and development in the 21st century: challenges, strategies, and solutions from a pharmaceutical industry perspective.
    Federsel HJ
    Acc Chem Res; 2009 May; 42(5):671-80. PubMed ID: 19338294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biocatalysis: synthesis of chiral intermediates for drugs.
    Patel RN
    Curr Opin Drug Discov Devel; 2006 Nov; 9(6):741-64. PubMed ID: 17117684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A consideration of the patentability of enantiomers in the pharmaceutical industry in the United States.
    Miller CP; Ullrich JW
    Chirality; 2008 Jun; 20(6):762-70. PubMed ID: 18200591
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.